P. Tonnesen (Gentofte, Denmark), R. Kessler (Strasbourg, France)
FEV1/FVC and FEV1/FEV6 in 8776 patients with normal lung function or COPD
A. Capderou, M. H. Becquemin, M. Berkani, T. Similowski, C. Straus, M. Zelter (Le Plessis Robinson, Paris, France)
|  |
Smoking cessation is associated with improved health status in COPD
J. B. Snoeck-Stroband, D. S. Postma, T. S. Lapperre, M. M. E. Gosman, H. A. Thiadens, H. F. Kauffman, J. K. Sont, P. J. Sterk (Lieden, Groningen, Netherlands)
| |
Relationship between exacerbation frequency and quality of life using the airways questionnaire 20 (AQ20) in a randomised controlled trial
A. Choudhury, J. Wedzicha, G. Feder, C. Griffiths (London, United Kingdom)
| |
Smoking cessation: a ‘heavy‘ decision during pulmonary rehabilitation
C. A. Weling-Scheepers, E. C. Creutzberg, E. J. Heber, E. F. Wouters (Horn, Maastricht, Netherlands)
| |
A ten year home-care program: preliminary data
S. Margherita, R. Maurizio, A. Arnaldo, P. Marica (Milan, Italy)
| |
Comparison of scores from a 40-item version of the SGRQ with the original version
E. A. Barley, M. Meguro, P. W. Jones (London, United Kingdom)
| |
Early diagnosis of COPD in Gdansk urban area-value of questionnaire and spirometry
R. K. Ucinska, J. M. Slominski (Gdansk, Poland)
| |
Acute bronchodilator responsiveness in a global respiratory trial (UPLIFT) following maximal inhaled bronchodilators
B. Celli, D. Tashkin, M. Decramer, D. Burkhart, C. Cassino, S. Kesten (Boston, Los Angeles, Ridgefield, United States Of America; Leuven, Belgium)
| |
Effect of oral N-acetylcysteine treatment on systemic inflammatory status in COPD patients
C. Koechlin, J. P. Cristol, M. Hayot, C. Prefaut (Montpellier, France)
| |
Effects of roflumilast and other PDE4 inhibitors on human CD8+ T-cell functions
H. Tenor, B. Burgbacher, C. Schudt, A. Hatzelmann (Konstanz, Germany)
| |
Tiotropium bromide (TIO) reduces hospitalizations in patients with COPD who had been refractory to treatment with combined inhaled corticosteroid/long acting beta agonist (ICS/LABA)
T. K. Lim, J. Phua, K. L. Khoo, L. K. Tan (Singapore, Singapore)
| |
Effects of roflumilast and other PDE4 inhibitors on [3H] thymidine incorporation in human bronchial smooth muscle cells
H. Tenor, E. Schatton, C. Schudt, A. Hatzelmann (Konstanz, Germany)
| |
Clinical improvement with salmeterol/fluticasone propionate (SFC) is associated with reduction in inflammation in patients with COPD
N. C. Barnes, Y. S. Qiu, I. Pavord, D. Parker, M. Johnson, N. Thomson, P. K. Jeffery (Leicester, Greenford, United Kingdom)
| |
Corticosteroids exaggerate the effect of cigarette smoke exposure on body weight and skeletal muscle mass in mice
M. J. Hansen, R. C. Gualano, S. Bozinovski, J. E. Jones, R. Vlahos, G. P. Anderson (Melbourne, Australia)
| |
Role of inhaled antioxidants in chronic obstructive pulmonary disease
D. Anderson, M. McLaughlin, E. Drost, W. MacNee (Edinburgh, United Kingdom)
| |
The relation of body mass index to survival and respiratory function in COPD patients
P. Argyropoulou, N. D. Manolakoglou, E. L. Tsiata, P. Kontou, J. Trigonis, T. Kontakiotis, G. Pitsiou, D. Patakas (Thessaloniki, Greece)
| |
1 year evolution of COPD patients systemic endothelial dysfunction
I. Agache, L. Duca (Brasov, Romania)
| |
Quality of life in patients with COPD. Results of EPIDEPOC study
P. Carrasco, J. de Miguel, M. Carballo, A. Gil, J. Rejas, A. Martin, E. Gobartt, R. Jimenez (Madrid, Barcelona, Spain)
| |
Depression cases in COPD patients related to increase of severity of airway obstruction
N. D. Voogd, J. Wempe, G. Koëter, K. Postema, R. Sanderman (Groningen, Netherlands)
| |
Effects of lisinipril on hypertensive COPD and asthma patients
S. S. Panina, O. O. Kharchenko, N. P. Nud‘ga, N. O. Gondulenko, S. V. Romamenko (Dniepropetrovsk, Ukraine)
| |